Anticancer agent 102

• Description:

  Anticancer agent 102 is a derivative of tetracaine. Anticancer agent 102 has anti-cancer activity. Anticancer agent 102 induces apoptosis[1].

• UNSPSC:

  12352005

• Target:

  Apoptosis

• Type:

  Reference compound

• Related Pathways:

  Apoptosis

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-102.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC=C(NCCCC)C=C1)N/N=C/C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2

• Molecular Formula:

  C20H19F6N3O

• Molecular Weight:

  431.37

• References & Citations:

  [1]M İhsan Han, et al. Design, Synthesis, and Anticancer Evaluation of Novel Tetracaine Hydrazide-Hydrazones. ACS Omega. 2023 Feb 28;8 (10) :9198-9211.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2914922-86-2]